The audit objective was to assess the effectiveness of the administration of the Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Gift to the Science and Industry Endowment Fund.

The objective of the audit was to assess the effectiveness of the award of funding under the first round of the Safer Streets programme.

The audit objective was to assess the effectiveness of the (former) Department of Industry’s administration of the Australian Apprenticeships Incentives Program.

The Auditor-General voluntarily discloses official expenses and they are updated here every six months. You can subscribe to be notified when the expenses are updated.

The objective of the Risk Framework and associated programs of risk management activities is to support effective risk management across all ANAO operations.

The Auditor-General undertook a limited assurance engagement of the Department of Finance’s management of the lease between the Commonwealth of Australia and the New South Wales Rifle Association over the Malabar Headland. The limited assurance engagement examined whether the management was, in all material respects, in accordance with the Commonwealth Property Management Framework.

The ANAO confirms its commitment to reconciliation with Aboriginal and Torres Strait Islander peoples through the development and implementation of this Reconciliation Action Plan (RAP).

The audit objective is to assess the effectiveness of the Department of Agriculture’s administration of the Imported Food Inspection Scheme.

The Auditor-General responded on 21 August 2018 to correspondence from Dr Jim Chalmers MP and Ms Michelle Rowland MP dated 26 July 2018, requesting that the Auditor-General conduct an assurance review of the financial assumptions underpinning the long-term economics of the NBN. 

The Auditor-General responded on 13 December 2021 to correspondence from Senator Jordon Steele-John dated 17 November 2021, requesting that the Auditor-General conduct an investigation to examine the administration of a Pharmaceutical Benefits Scheme program for opioid dependency treatment.